S100A10 and liver cancer: Furthermore, the KM curve analysis demonstrated that patients with elevated S100A10 expression have a poorer prognosis, and S100A10 expression can also serve as a predictor for the 1-year, 2-year, and 3-year prognosis of liver cancer patients (Figures 9D, E).